0.91 (1.03%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Weak
Earnings
Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Dianthus Therapeutics, Inc.
Telephone
1.929.999.4055
Address
43rd Floor, 7 Times Square, New York, NY 10036
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 16.64 - 96.5
Trade Value (12mth)
US$8,921,564.00
1 week
2.97%
1 month
-2.82%
YTD
123.59%
1 year
383.22%
All time high
336.00
EPS 3 yr Growth
-87.10%
EBITDA Margin
NaN%
Operating Cashflow
-$129m
Free Cash Flow Return
-30.40%
ROIC
-38.30%
Interest Coverage
0.00
Quick Ratio
13.30
Shares Outstanding (Fully Diluted)
48m
HALO Sector
Healthcare
Next Company Report Date
16-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 06 May 26 | |
| 06 May 26 | |
| 06 May 26 | |
| 06 May 26 | |
| 23 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -8.45 | -2.55 | -4.2 | | | | ||
EPS (Fully Diluted) | $ | | | | | -8.45 | -2.55 | -4.2 | | | | ||
Growth | % | | | | | 74.1 | 69.8 | -64.8 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
